Management of adverse events associated with cabozantinib plus nivolumab in renal cell carcinoma: A review
Bradley A. McGregor, Amir Mortazavi, Lisa M. Cordes, Cristina Salabao, Susan Vandlik, Andrea B. Apolo
Topics & Concepts
NivolumabMedicineCabozantinibRenal cell carcinomaSunitinibAdverse effectAxitinibTyrosine-kinase inhibitorTolerabilityKidney cancerOncologyInternal medicineImmunotherapyCancerRenal cell carcinoma treatmentPancreatic and Hepatic Oncology ResearchCancer Immunotherapy and Biomarkers